NCT06103188

Brief Summary

The goal of this clinical trial is to compare the effect of melatonin, diazepam, and placebo on the level of anxiety in patients undergoing surgery. The main question it aims to answer is: • Is melatonin effective in reducing the anxiety of patients undergoing surgery? Participants will be asked to answer a questionnaire then they will receive either melatonin, diazepam, or placebo, and then after an hour, they will answer the same questionnaire again. Researchers will compare melatonin, diazepam, and placebo to see if melatonin is as effective in reducing the level of anxiety as diazepam in patients undergoing surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P25-P50 for phase_3 anxiety

Timeline
Completed

Started Oct 2023

Shorter than P25 for phase_3 anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2023

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

October 21, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 26, 2023

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 24, 2025

Completed
Last Updated

January 24, 2025

Status Verified

December 1, 2024

Enrollment Period

28 days

First QC Date

October 21, 2023

Results QC Date

July 6, 2024

Last Update Submit

December 20, 2024

Conditions

Keywords

Preoperative anxietyAnxiolyticMelatoninDiazepamSedationPremedication

Outcome Measures

Primary Outcomes (2)

  • Change in the Anxiety Score Using the Visual Analogue Score for Anxiety Between Treatment Arms

    VAS (Visual Analogue Score) Anxiety Scale is a 100 mm long scale. The scale is marked in millimeters from 0 to 100, where 0 correlates with no anxiety at all, and 100 correlates to anxiety as bad as possible. The maximum score is 100 and minimum 0. The patient is asked to point on the scale according to his anxiety level. The more the reduction in anxiety from baseline, the better the outcome.

    Before administration of premedication, and after 1 hour from the administration of the premedication.

  • Change in Anxiety Score Based on The Amsterdam Preoperative Anxiety and Information Scale (APAIS) Between Treatment Arms

    The Amsterdam Preoperative Anxiety and Information Scale (APAIS) is a self-reported questionnaire. The scale consists of six items, four of which assess the patient's anxiety, while the last two assess the patients' need-for-information and the patient must choose how much he agrees with each item on a scale of 1 (not at all) to 5 (very much). The scores of each item are summed to provide the total score. The minimum score possible is 6 and the maximum score is 30, the higher the score the higher the anxiety level and need for information. The scale consists of two subscales: Need for Information subscale: consists of two items (minimum score of 2 and maximum score of 10, the higher the score the more need for information). Anxiety subscale: consists of four items (minimum score of 4 and maximum score of 20, the higher the score the higher the anxiety level). The total scale is the sum of the two subscales.

    Before administration of premedication, and after 1 hour from the administration of the premedication.

Secondary Outcomes (2)

  • Change in Sedation Between Treatment Arms

    Before administration of premedication, and after 1 hour from the administration of the premedication.

  • Change in Orientation Between Treatment Arms

    Before administration of premedication, and after 1 hour from the administration of the premedication.

Other Outcomes (4)

  • Change in the Anxiety Score Using the Visual Analogue Score for Anxiety Between Genders

    Before administration of premedication, and after 1 hour from the administration of the premedication.

  • Change in Anxiety Score Based on The Amsterdam Preoperative Anxiety and Information Scale (APAIS) Between Genders

    Before administration of premedication, and after 1 hour from the administration of the premedication.

  • Change in Sedation Between Genders

    Before administration of premedication, and after 1 hour from the administration of the premedication.

  • +1 more other outcomes

Study Arms (3)

Placebo

PLACEBO COMPARATOR

A 5mg vitamin B12 pill

Drug: Placebo

Diazepam

ACTIVE COMPARATOR

A 5mg diazepam pill

Drug: Diazepam

Melatonin

EXPERIMENTAL

A 5mg melatonin pill

Drug: Melatonin

Interventions

The placebo pill will be given to the patients 1 hour prior to their planned surgery.

Placebo

Diazepam will be given to the patients 1 hour prior to their planned surgery.

Diazepam

Melatonin will be given to the patients 1 hour prior to their planned surgery.

Melatonin

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 1 or 2
  • Posted for general anesthesia
  • Aging between 18 and 65 years

You may not qualify if:

  • Allergy to any of the drugs under study
  • Pregnancy
  • Illiteracy
  • Any mental illness
  • Taking antipsychotics, antidepressants, anxiolytics, or sedatives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordan University Hospital

Amman, Jordan

Location

Related Publications (1)

  • Ismail O, Albdour K, Jaber K, Jaber Y, Alsaras A, Younis A, Froukh U, Momani Y, Abu-Halaweh S. The efficacy of melatonin as a preoperative anxiolytic in real-world setting: a randomized controlled trial. Hosp Pract (1995). 2025 Feb;53(1):2600245. doi: 10.1080/21548331.2025.2600245. Epub 2025 Dec 9.

MeSH Terms

Conditions

Anxiety Disorders

Interventions

DiazepamMelatonin

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

BenzodiazepinonesBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsTryptaminesIndolesHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Results Point of Contact

Title
Dr Omar Ismail
Organization
Jordan University Hospital

Study Officials

  • Omar Ismail

    University of Jordan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 21, 2023

First Posted

October 26, 2023

Study Start

October 2, 2023

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

January 24, 2025

Results First Posted

January 24, 2025

Record last verified: 2024-12

Locations